Klunk, W E <br/><br/>
Inactivity of phosphoethanolamine, an endogenous GABA analog decreased in Alzheimer's disease, at GABA binding sites.  [electronic resource] 

 -  Life sciences  1995 
 - 2377-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0024-3205 
<br/><br/><label>Standard No.: </label>10.1016/0024-3205(95)00231-t  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--metabolism<br/>Animals<br/>Ethanolamines--metabolism<br/>GABA-A Receptor Antagonists<br/>Male<br/>Muscimol--metabolism<br/>Pyridazines--metabolism<br/>Rats<br/>Rats, Inbred F344<br/>Receptors, GABA--metabolism<br/>Receptors, GABA-A--metabolism<br/>Receptors, GABA-B--metabolism<br/>Tritium<br/>gamma-Aminobutyric Acid--analogs & derivatives